The agency first approved Sutent in 2006 to treat patients with gastrointestinal stromal tumors and advanced kidney cancer. The drug has also been approved to treat a certain form of pancreatic cancer.
Under the latest approval, Sutent may now be used to treat patients who’ve had a kidney surgically removed to lower the risk of cancer recurrence. Sutent is the first drug approved for this indication.
More articles on supply chain:
Geisinger, Intermountain among 11 healthcare groups urging CMS to add device identifiers to claims form
Genentech earns FDA approval for hemophilia drug
6 must-reads for supply chain leaders this week
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
